Fri.Oct 13, 2023

article thumbnail

Assessing, Implementing Geriatric Oncology Model of Care for Lung Cancer Patients

Drug Topics

Geriatric screening and assessment have not been widely used, despite international society recommendations for screening older patients with cancer.

460
460
article thumbnail

Opinion: Yes, everyone should get an updated Covid-19 vaccine

STAT

Last month, the Centers for Disease Control and Prevention recommended that everyone in the U.S. 6 months and older receive an updated Covid vaccine targeting the XBB.1.5 variant. Since then, some notable voices, including Paul Offit , have publicly questioned whether the updated vaccine is needed for those who are not in a high-risk group. He recently wrote, “At this point in the pandemic, it is hard to make a case for vaccinating everyone.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conference Preview: NCPA 2023 Annual Convention and Expo

Drug Topics

This year’s meeting will take place from October 14–17 in Orlando, Florida.

247
247
article thumbnail

STAT+: Like a vampire, some cancer cells can suck the energy source from immune cells

STAT

As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Patient Perceptions of Benefits, Barriers in Diabetes Technologies

Drug Topics

Patients with type 1 diabetes who use technologies for glycemic management may perceive these devices as important for glucose monitoring and emotion well-being, but affordability remains a significant barrier.

247
247
article thumbnail

He was named a MacArthur ‘genius’ fellow for research on gene regulation, but still has imposter syndrome

STAT

The youngest of this year’s class of MacArthur “genius grant” fellows, 35-year-old Jason Buenrostro was just a graduate student when he pioneered a technique that’s become a mainstay for studying how cells regulate gene expression. While doing his doctoral work at Stanford University, with geneticists William Greenleaf and Howard Chang, he developed the assay for transposase-accessible chromatin, or ATAC-seq, a highly sensitive and accurate method for identifying regi

141
141

More Trending

article thumbnail

Removal of Phenylephrine From Nasal Decongestants Could Reshape OTC Cold Remedies

Pharmacy Times

Intranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.

139
139
article thumbnail

STAT+: Amgen reports first clinical data on new targeted cancer therapy

STAT

It’s been a busy week for a cancer drug target called PRMT5 that may play a role in treating a variety of solid tumors. Amgen on Friday presented preliminary results from its first study of an experimental pill that selectively blocks the enzyme in cancer cells, showing five partial responses from 31 evaluable patients. The Amgen reveal followed the announcement on Sunday that a rival PRMT5 inhibitor being developed by Mirati Therapeutics factored into Bristol Myers Squibb’s decisi

135
135
article thumbnail

Accessibility of OTC Short-Acting Beta-2 Agonists Contributes to Overuse for Asthma

Pharmacy Times

Many patients would like more education about managing their asthma, which can help to reduce the overuse of short-acting beta-2 agonists.

139
139
article thumbnail

Kaiser Permanente reaches tentative agreement with workers

STAT

After a historic strike, healthcare giant Kaiser Permanente and the Coalition of Kaiser Permanente Unions announced early Friday that they have reached a tentative union contract agreement. More details will be disclosed soon, they said. The agreement was reached with the help of acting U.S. Labor Secretary Julie Su, who was also on hand for the failed last-minute set of negotiation talks before the unions went on strike last week.

Hospitals 134
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Deep Sleep With Pink Noise Increases Benefits to Cardiovascular System

Pharmacy Times

A study shows a significant increase in left ventricular ejection fraction when using pink noise stimulation with deep sleep.

132
132
article thumbnail

STAT+: Medicare to cover more brain scans related to Alzheimer’s drugs

STAT

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday. Amyloid PET scans are important tools to help determine whether patients with mild cognitive impairment are good candidates for new Alzheimer’s drugs, including Eisai and Biogen’s drug Leqembi , which means there will likely be an increase in demand for the scans as uptake increases.

134
134
article thumbnail

Study Finds Mental Health-Related Emergency Department Visits Dropped in 2020, Began Increasing in Mid-2021

Pharmacy Times

Adolescents with mental health conditions must be monitored as they are at a higher demand for the need of mental health care.

132
132
article thumbnail

STAT+: European regulators once again recommend Amylyx’s ALS drug be rejected

STAT

LONDON — European regulators on Friday reiterated their view that an ALS treatment from Amylyx Pharmaceuticals should not be approved, likely dooming the drug’s chances for now.   A European Medicines Agency committee had initially recommended against approving the drug , known as Albrioza, in June. Friday’s confirmation of that position came after the company appealed the decision.

131
131
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

UnitedHealth posts $5.8B in profit, $92.4B in revenue on Q3 beat

Fierce Healthcare

UnitedHealth Group kicked off another round of quarterly earnings calls Friday morning, when it reported $5.8 billion in profit for the third quarter. | UnitedHealth Group kicked off another round of quarterly earnings calls on Friday morning, where it reported $5.8 billion in profit for the third quarter.

130
130
article thumbnail

The PharmaVoice 100: Patient heroes

PharmaVoice

Leaders innovating new ways to incorporate patient voices in drug development and decrease barriers to access.

130
130
article thumbnail

Medicare Advantage plan star ratings decline again in 2024

Fierce Healthcare

Approximately 42% of Medicare Advantage plans that offer prescription drug coverage will have a star rating of four or more in 2024, marking yet another substantial decrease from

127
127
article thumbnail

Branded: The trademarks pharma leaders look up to

PharmaVoice

What do brands like Patagonia, Nike and Lego have to do with pharma? Here are some of the brands industry leaders relate to most — and how they inspire work in the life sciences.

130
130
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Vampiric cancer cells, a brain atlas, & alleged misconduct at Cassava

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Today, we learn about energy-sucking cancer cells, explore a map of the human brain, and update you on the downfall of Cassava Sciences. Have a good weekend.

126
126
article thumbnail

CMS is removing PET scan restrictions for Alzheimer’s patients

Fierce Healthcare

The Centers for Medicare & Medicaid Services has decided to remove the national coverage determination (NCD) that limits patients’ ability to qualify for new drugs, giving people with Alzheimer | After CMS floated the idea in July, the agency decided to remove restrictions for brain scans that could help patients receive access to drugs like Leqembi.

125
125
article thumbnail

STAT+: Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin

STAT

Due to a shortage of a widely used compounded medicine for serious eye diseases, two leading ophthalmologic groups want Medicare contractors to halt practices that limit coverage of other — albeit costlier — treatments over concerns about patient access. At issue is Avastin, an older cancer medicine that is often used by physicians to treat age-related macular degeneration and macular edema, among other ailments.

Insurance 125
article thumbnail

Uptake, Acceptability of HIV Pre-Exposure Prophylaxis Treatment Influenced by Knowledge, Perception of Risk in MSM

Pharmacy Times

Although increased knowledge and understanding could increase uptake and acceptability of pre-exposure prophylaxis for HIV, action is needed to remove barriers and improve accessibility.

123
123
article thumbnail

An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs

PharmExec

Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.

119
119
article thumbnail

STAT+: UnitedHealth’s profit jumps as medical costs come in lower than expected

STAT

UnitedHealth Group has made it clear that more people, especially older adults, are seeing their doctors and getting more medical care this year. But that is certainly not dragging down the company’s profits. In the third quarter of this year, UnitedHealth’s net profit increased by more than 11%, to more than $5.8 billion, the company reported Friday.

Insurance 117
article thumbnail

International Delight preps for the holidays with Grinch-themed flavors

Drug Store News

International Delight has the holiday season in mind with new coffee and creamer offerings inspired by The Grinch.

111
111
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

112
112
article thumbnail

Children 5 and younger may be particularly vulnerable to flu and should be vaccinated: CDC study

Fierce Healthcare

Youngsters 5 to 17 years old need to get vaccinated against influenza as soon as possible. | Children and adolescents should receive the seasonal influenza vaccination by the end of October, according to the Centers for Disease Control and Prevention.

Vaccines 111
article thumbnail

FDA fast tracks MimiVax’s glioblastoma vaccine SurVaxM

Pharmaceutical Technology

The Phase IIb SurVaxM vaccine study will enrol 265 patients and has an estimated completion date in Q2 2024.

Vaccines 111
article thumbnail

Follicular lymphoma BTK inhibitor recommended by CHMP

European Pharmaceutical Review

The Committee for Medicinal Products for Human Use (CHMP) has recommended approval of BRUKINSA ® (zanubrutinib), a Bruton’s tyrosine kinase inhibitor (BTKi), in combination with obinutuzumab. BeiGene’s anti-cancer treatment is indicated for adults with relapsed or refractory (R/R) follicular lymphoma (FL) who have received at least two prior lines of systemic therapy.

Labelling 111
article thumbnail

FDA lifts clinical hold on PepGen’s myotonic dystrophy type 1 candidate

Pharmaceutical Technology

The dose-selection Phase I trials for evaluating PepGen’s peptide-conjugated antisense oligonucleotide have been cleared to begin in the US.

FDA 111
article thumbnail

Perricone MD blurs pores, preps skin for makeup application

Drug Store News

The No Makeup Instant Blur Priming Moisturizer aims to minimize the look of pores, redness, lines and wrinkles.

106
106
article thumbnail

Santhera closes on first approval for DMD drug vamorolone

pharmaphorum

Santhera closes on first approval for DMD drug vamorolone Phil.

105
105
article thumbnail

Todd Vasos returns as CEO of Dollar General

Drug Store News

Vasos, who previously served as Dollar General’s CEO from June 2015 to November 2022, is returning as CEO, succeeding Jeff Owen, whose separation from the company and resignation from its board is effective today.

106
106